252 related articles for article (PubMed ID: 21121985)
1. Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy.
Au CG; Butler TL; Sherwood MC; Egan JR; North KN; Winlaw DS
Int J Exp Pathol; 2011 Feb; 92(1):57-65. PubMed ID: 21121985
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.
Dahiya S; Givvimani S; Bhatnagar S; Qipshidze N; Tyagi SC; Kumar A
J Immunol; 2011 Sep; 187(5):2723-31. PubMed ID: 21810612
[TBL] [Abstract][Full Text] [Related]
3. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
Wasala NB; Bostick B; Yue Y; Duan D
Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
[TBL] [Abstract][Full Text] [Related]
4. Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFβ1 signaling in the mdx mouse model of Duchenne muscular dystrophy.
Ieronimakis N; Hays AL; Janebodin K; Mahoney WM; Duffield JS; Majesky MW; Reyes M
J Mol Cell Cardiol; 2013 Oct; 63():122-34. PubMed ID: 23911435
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
Morales MG; Cabrera D; Céspedes C; Vio CP; Vazquez Y; Brandan E; Cabello-Verrugio C
Cell Tissue Res; 2013 Jul; 353(1):173-87. PubMed ID: 23673415
[TBL] [Abstract][Full Text] [Related]
6. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
[TBL] [Abstract][Full Text] [Related]
7. Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in
Mareedu S; Pachon R; Thilagavathi J; Fefelova N; Balakrishnan R; Niranjan N; Xie LH; Babu GJ
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H200-H210. PubMed ID: 33216625
[TBL] [Abstract][Full Text] [Related]
8. Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart.
Spurney CF; Knoblach S; Pistilli EE; Nagaraju K; Martin GR; Hoffman EP
Neuromuscul Disord; 2008 May; 18(5):371-81. PubMed ID: 18440230
[TBL] [Abstract][Full Text] [Related]
9. Diaphragm degeneration and cardiac structure in mdx mouse: potential clinical implications for Duchenne muscular dystrophy.
Barbin IC; Pereira JA; Bersan Rovere M; de Oliveira Moreira D; Marques MJ; Santo Neto H
J Anat; 2016 May; 228(5):784-91. PubMed ID: 26822140
[TBL] [Abstract][Full Text] [Related]
10. Normalization of connexin 43 protein levels prevents cellular and functional signs of dystrophic cardiomyopathy in mice.
Gonzalez JP; Ramachandran J; Himelman E; Badr MA; Kang C; Nouet J; Fefelova N; Xie LH; Shirokova N; Contreras JE; Fraidenraich D
Neuromuscul Disord; 2018 Apr; 28(4):361-372. PubMed ID: 29477453
[TBL] [Abstract][Full Text] [Related]
11. Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment.
Ballmann C; Hollinger K; Selsby JT; Amin R; Quindry JC
Exp Physiol; 2015 Jan; 100(1):12-22. PubMed ID: 25557727
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Wilms' Tumor 1 in epicardial cells increases cardiac fibrosis in dystrophic mice.
Guo Z; Geng M; Huang Y; Han G; Jing R; Lin C; Zhang X; Zhang M; Fan G; Wang F; Yin H
Cell Death Differ; 2022 Oct; 29(10):1928-1940. PubMed ID: 35306537
[TBL] [Abstract][Full Text] [Related]
13. Timeline of cardiac dystrophy in 3-18-month-old MDX mice.
Van Erp C; Loch D; Laws N; Trebbin A; Hoey AJ
Muscle Nerve; 2010 Oct; 42(4):504-13. PubMed ID: 20589894
[TBL] [Abstract][Full Text] [Related]
14. Acute AT
Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
[TBL] [Abstract][Full Text] [Related]
15. Exosome-Derived Dystrophin from Allograft Myogenic Progenitors Improves Cardiac Function in Duchenne Muscular Dystrophic Mice.
Su X; Jin Y; Shen Y; Ju C; Cai J; Liu Y; Kim IM; Wang Y; Yu H; Weintraub NL; Jiang M; Tang Y
J Cardiovasc Transl Res; 2018 Oct; 11(5):412-419. PubMed ID: 30155598
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.
Delfín DA; Zang KE; Schill KE; Patel NT; Janssen PM; Raman SV; Rafael-Fortney JA
Neuromuscul Disord; 2012 Nov; 22(11):1006-14. PubMed ID: 22749475
[TBL] [Abstract][Full Text] [Related]
17. Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
Spurney CF; Guerron AD; Yu Q; Sali A; van der Meulen JH; Hoffman EP; Nagaraju K
BMC Cardiovasc Disord; 2011 May; 11():20. PubMed ID: 21575230
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
19. Long-term administration of pirfenidone improves cardiac function in mdx mice.
Van Erp C; Irwin NG; Hoey AJ
Muscle Nerve; 2006 Sep; 34(3):327-34. PubMed ID: 16770778
[TBL] [Abstract][Full Text] [Related]
20. Identification of critical molecular pathways involved in exosome-mediated improvement of cardiac function in a mouse model of muscular dystrophy.
Su X; Shen Y; Jin Y; Weintraub NL; Tang YL
Acta Pharmacol Sin; 2021 Apr; 42(4):529-535. PubMed ID: 32601364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
